[{"AccountsPayableCurrent_0_Q3_USD":4714000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":13000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":4892000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":4405000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":895000.0,"OperatingIncomeLoss_3_Q3_USD":-83017000.0,"OperatingIncomeLoss_1_Q3_USD":-25674000.0,"OperatingExpenses_3_Q3_USD":83370000.0,"OperatingExpenses_1_Q3_USD":25783000.0,"NontradeReceivablesCurrent_0_Q3_USD":610000.0,"NetIncomeLoss_3_Q3_USD":-84095000.0,"NetIncomeLoss_1_Q3_USD":-26697000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-73388000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":63582000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":28917000.0,"LongTermDebtNoncurrent_0_Q3_USD":34669000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q3_USD":796000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q3_USD":19187000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q3_USD":18338000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q3_USD":5858000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-62000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-77000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":1106000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":116482000.0,"StockholdersEquity_0_Q3_USD":151553000.0,"ShareBasedGoodsAndNonemployeeServicesTransactionStockholdersEquity_1_Q3_USD":23000.0,"ShareBasedCompensation_3_Q3_USD":5775000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":353000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":109000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1239724000.0,"RestrictedInvestmentsAtFairValue_0_Q3_USD":363000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q3_USD":363000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3_Q3_USD":61577000.0,"LiabilitiesCurrent_0_Q3_USD":38470000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q3_USD":18527000.0,"ProfitLoss_3_Q3_USD":-84095000.0,"ProceedsFromWarrantExercises_3_Q3_USD":2479000.0,"ProceedsFromSaleOfOtherAssetsInvestingActivities_3_Q3_USD":1594000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":178574000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":204000.0,"ProceedsFromIssuanceOfLongTermDebt_3_Q3_USD":10000000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":16234000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":2262000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":104000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":608000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":328934491.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":229097000.0,"InvestmentIncomeInterest_3_Q3_USD":421000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":29399000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q3_USD":24805000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":29036000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":39362000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":147084000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":186446000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":186430000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":38000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":54000.0,"AssetsCurrent_0_Q3_USD":179355000.0,"Assets_0_Q3_USD":229097000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":627000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":5775000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":2008000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2008000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1390940000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":16000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":26246000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-1137000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":19111000.0,"CashEquivalentsAtCarryingValue_0_Q3_USD":24805000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CommonStockValue_0_Q3_USD":321000.0,"InvestmentIncomeInterest_1_Q3_USD":112000.0,"InterestPayableCurrentAndNoncurrent_0_Q3_USD":6887000.0,"InterestExpense_3_Q3_USD":2605000.0,"InterestExpense_1_Q3_USD":1058000.0,"IncreaseDecreaseInOperatingLiabilities_3_Q3_USD":7136000.0,"IncreaseDecreaseInOperatingAssets_3_Q3_USD":3363000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":21793000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":7256000.0,"GainLossOnSaleOfEquityInvestments_3_Q3_USD":1233000.0,"IssuanceOfStockAndWarrantsForServicesOrClaims_3_Q3_USD":71000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":6615000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.08,"DepreciationAndAmortization_3_Q3_USD":154000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q3_USD":38000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q3_USD":72445000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q3_USD":38000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q3_USD":72445000.0,"DebtInstrumentUnamortizedDiscount_0_Q3_USD":836000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-84157000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-26684000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.26,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":326552763.0,"Ticker":"GERN","CIK":"886744","name":"GERON CORP","OfficialName":"Geron Corporation Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"565597388.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211109"}]